Literature DB >> 21473808

Hematopoietic derived cell infiltration of the intestinal tumor microenvironment in Apc Min/+ mice.

Celestia Davis1, Robert Price, Grishma Acharya, Troy Baudino, Thomas Borg, Franklin G Berger, Maria Marjorette O Peña.   

Abstract

Tumors consist of a heterogeneous population of neoplastic cells infiltrated by an equally heterogeneous collection of nonneoplastic cells that comprise the tumor microenvironment. Tumor growth, invasion, and metastasis depend on multiple interactions between these cells. To assess their potential as therapeutic targets or vehicles for tumor specific delivery of therapeutic agents, we examined the contribution of bone marrow derived cells (BMDCs) to the intestinal tumor microenvironment. Hematopoietic stem cells expressing the enhanced green fluorescent protein (eGFP) were transplanted into lethally irradiated ApcMin/+ mice, and their engraftment was analyzed by confocal microscopy. The results showed abundant infiltration of eGFP cells into the small intestine, colon, and spleen compared to heart, muscle, liver, lung, and kidney. Within the intestine, there was a pronounced gradient of engraftment along the anterior to posterior axis, with enhanced infiltration into adenomas. Immunofluorescence analysis showed that osteopontin was expressed in tumor stromal cells but not in nontumor stromal populations, suggesting that gene expression in these cells is distinct. Tumor vasculature in ApcMin/+ mice was chaotic compared to normal intestinal regions. Our data suggest that BMDCs can be harnessed for tumor-targeted therapies to enhance antitumor efficacy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21473808      PMCID: PMC3362927          DOI: 10.1017/S1431927611000043

Source DB:  PubMed          Journal:  Microsc Microanal        ISSN: 1431-9276            Impact factor:   4.127


  53 in total

1.  Hematopoietic origin of glomerular mesangial cells.

Authors:  Masahiro Masuya; Christopher J Drake; Paul A Fleming; Christopher M Reilly; Haiqun Zeng; William D Hill; Angeline Martin-Studdard; David C Hess; Makio Ogawa
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

2.  Coevolution of cancer and stromal cellular responses.

Authors:  Laurie E Littlepage; Mikala Egeblad; Zena Werb
Journal:  Cancer Cell       Date:  2005-06       Impact factor: 31.743

3.  Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia.

Authors:  O Kitahara; Y Furukawa; T Tanaka; C Kihara; K Ono; R Yanagawa; M E Nita; T Takagi; Y Nakamura; T Tsunoda
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

4.  Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells.

Authors:  Eva Obermueller; Silvia Vosseler; Norbert E Fusenig; Margareta M Mueller
Journal:  Cancer Res       Date:  2004-11-01       Impact factor: 12.701

5.  CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice.

Authors:  Susan E Erdman; Jane J Sohn; Varada P Rao; Prashant R Nambiar; Zhongming Ge; James G Fox; David B Schauer
Journal:  Cancer Res       Date:  2005-05-15       Impact factor: 12.701

Review 6.  Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer.

Authors:  Robert R Jenq; Marcel R M van den Brink
Journal:  Nat Rev Cancer       Date:  2010-02-19       Impact factor: 60.716

7.  T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis.

Authors:  Elias Gounaris; Nichole R Blatner; Kristen Dennis; Fay Magnusson; Michael F Gurish; Terry B Strom; Philipp Beckhove; Fotini Gounari; Khashayarsha Khazaie
Journal:  Cancer Res       Date:  2009-07-01       Impact factor: 12.701

Review 8.  Anti-cancer therapies targeting the tumor stroma.

Authors:  Valeska Hofmeister; David Schrama; Jürgen C Becker
Journal:  Cancer Immunol Immunother       Date:  2007-07-27       Impact factor: 6.968

9.  Stromal cell protection of B-lineage acute lymphoblastic leukemic cells during chemotherapy requires active Akt.

Authors:  Lin Wang; James E Fortney; Laura F Gibson
Journal:  Leuk Res       Date:  2004-07       Impact factor: 3.156

10.  CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice.

Authors:  Susan E Erdman; Varada P Rao; Theofilos Poutahidis; Melanie M Ihrig; Zhongming Ge; Yan Feng; Michal Tomczak; Arlin B Rogers; Bruce H Horwitz; James G Fox
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

View more
  1 in total

1.  Osteopontin mediates an MZF1-TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer.

Authors:  C E Weber; A N Kothari; P Y Wai; N Y Li; J Driver; M A C Zapf; C A Franzen; G N Gupta; C Osipo; A Zlobin; W K Syn; J Zhang; P C Kuo; Z Mi
Journal:  Oncogene       Date:  2014-12-22       Impact factor: 9.867

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.